Of particular importance, as a candidate mediator of TKI resistance, the increased expression of HGF can lead to activation and amplification of the c-MET receptor in cancer cells and tumor-associated stroma, which is closely related to the acquired resistance to EGFR-TKIs [55,56,57]. Here, HGF is linked to cancer.